title: A phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma.
authors.affiliation: Department of Medicine, University of Toronto, Ontario.
authors.forename: A K
authors.initials: AK
authors.lastname: Stewart
authors.forename: N J
authors.initials: NJ
authors.lastname: Lassam
authors.forename: F L
authors.initials: FL
authors.lastname: Graham
authors.forename: J
authors.initials: J
authors.lastname: Gauldie
authors.forename: C L
authors.initials: CL
authors.lastname: Addison
authors.forename: D J
authors.initials: DJ
authors.lastname: Bailey
authors.forename: S
authors.initials: S
authors.lastname: Dessureault
authors.forename: I D
authors.initials: ID
authors.lastname: Dubé
authors.forename: S
authors.initials: S
authors.lastname: Gallenger
authors.forename: M
authors.initials: M
authors.lastname: Krajden
authors.forename: L E
authors.initials: LE
authors.lastname: Rotstein
authors.forename: I C
authors.initials: IC
authors.lastname: Quirt
authors.forename: R
authors.initials: R
authors.lastname: Moen
mesh_terms: D000256:Adenoviridae / Q000235:genetics* / Q000502:physiology; D000257:Adenoviridae Infections / Q000209:etiology / Q000635:transmission; D000818:Animals; D001943:Breast Neoplasms / Q000628:therapy*; D002985:Clinical Protocols; D004195:Disease Models, Animal; D005260:Female; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods* / Q000592:standards; D005822:Genetic Vectors; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000235:genetics / Q000627:therapeutic use*; D008545:Melanoma / Q000628:therapy*; D051379:Mice; D008822:Mice, Transgenic; D010865:Pilot Projects; D012307:Risk Factors; D014779:Virus Replication
chemical_list: D007376:Interleukin-2